Form Type: 4

SEC EDGAR Link
Accession Number:0001209191-21-052213
Date:2021-08-16
Issuer: CERIDIAN HCM HOLDING INC. (CDAY)
Original Submission Date:

Reporting Person:

JACOBS JEFFREY SCOTT
C/O CERIDIAN HCM HOLDING INC.
3311 E. OLD SHAKOPEE ROAD MINNEAPOLIS, MN 55425

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2021-08-16 M 2,000 a $16.82 6,840 direct
COMMON STOCK 2021-08-16 S 1,021 d $104.49 5,819 direct
COMMON STOCK 2021-08-16 S 979 d $105.07 4,840 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
OPTION (RIGHT TO BUY) 16.82 2021-08-16 deemed execution date M 2,000 (d) 2026-12-31 common stock 2,000 $16.82 2,125 direct
OPTION (RIGHT TO BUY) 17.58 deemed execution date 0 ( ) 2025-12-08 common stock 500 $17.58 500 direct
OPTION (RIGHT TO BUY) 19.04 deemed execution date 0 ( ) 2027-12-20 common stock 5,000 $19.04 5,000 direct
OPTION (RIGHT TO BUY) 22.0 deemed execution date 0 ( ) 2028-04-25 common stock 32,610 $22.00 32,610 direct
OPTION (RIGHT TO BUY) 44.91 deemed execution date 0 ( ) 2029-02-08 common stock 712 $44.91 712 direct
OPTION (RIGHT TO BUY) 49.93 deemed execution date 0 ( ) 2029-03-20 common stock 8,396 $49.93 8,396 direct
OPTION (RIGHT TO BUY) 65.26 deemed execution date 0 ( ) 2030-05-08 common stock 14,299 $65.26 14,299 direct
PERFORMANCE UNITS 0.0 deemed execution date 0 ( ) 2022-03-08 common stock 593 $0.00 593 direct
PERFORMANCE UNITS 0.0 deemed execution date 0 ( ) 2024-03-08 common stock 2,470 $0.00 2,470 direct
Footnotes
IDfootnote
f1 the sales reported on this form 4 were effected pursuant to a rule 10b5-1 trading plan.
f2 the price reported in column 4 is a weighted average price. these shares were sold in multiple transactions at prices ranging from $103.78 to $104.77 inclusive. the reporting person undertakes to provide ceridian hcm holding inc., any security holder of ceridian hcm holding inc. or the staff of the securities and exchange commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
f3 the price reported in column 4 is a weighted average price. these shares were sold in multiple transactions at prices ranging from $104.78 to $105.55 inclusive. the reporting person undertakes to provide ceridian hcm holding inc., any security holder of ceridian hcm holding inc. or the staff of the securities and exchange commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
f4 includes (i) 1,200 shares of common stock, which includes 79 shares acquired under the ceridian hcm holding inc. global employee stock purchase plan on june 30, 2021, (ii) shares issuable pursuant to restricted stock units (rsus), granted on february 28, 2020, of which 74 shares vest on each of february 28, 2022 and february 28, 2023, (iii) shares issuable pursuant to rsus, granted on may 8, 2020, of which 511 shares vest on each of may 8, 2022 and may 8, 2023; and (iv) shares that are issuable pursuant to rsus, granted on march 8, 2021, of which 823 shares vest on each of march 8, 2022 and march 8, 2023 and 824 shares that vest on march 8, 2024.
f5 fully vested and exercisable.
f6 not applicable
f7 consists of 3,750 vested and exercisable options and 1,250 options that vest and become exercisable on december 20, 2021.
f8 consists of 24,457 vested and exercisable options and 8,153 options that vest and become exercisable on april 25, 2022.
f9 consists of 356 vested and exercisable options and 178 options that vest and become exercisable on each of february 8, 2022 and february 8, 2023.
f10 consists of 4,198 vested and exercisable options and 2,099 options that vest and become exercisable on each of march 20, 2022 and march 20, 2023.
f11 consists of 3,574 vested and exercisable options and 3,575 options that vest and become exercisable on each of may 8, 2022, may 8, 2023, and may 8, 2024.
f12 each performance stock unit represents a contingent right to receive between .25 and 1.50 shares of common stock based upon the degree to which one or both of the cloud revenue and adjusted ebitda margin performance metrics under the companys 2021 management incentive plan are satisfied. the performance stock units vest upon the later of (i) the date the compensation committee or the board certify that one or both of the performance metrics have been met and (ii) march 8, 2022.
f13 each performance stock unit represents a contingent right to receive between .25 and 1.50 shares of common stock based upon the degree to which one or both of the cloud revenue and adjusted ebitda margin performance metrics contained in the performance stock unit award agreement are satisfied. the performance stock units will only vest if the achievement of one or both of the performance metrics is certified by the compensation committee or the board of directors of the company to have been met, and then any such certified amount will vest one-third on each anniversary of the date of grant.
WhaleWisdom Logo

Elevate your investments